Innovent Biologics Inc. (IVBXF) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Innovent Biologics Inc.

    OTC: IVBXF · Real-Time Price · USD
    12.72
    0.34 (2.75%)
    At close: Oct 03, 2025, 1:56 PM
    12.50
    -1.73%
    After-hours: Oct 02, 2025, 12:07 PM EDT

    Innovent Biologics Cash Flow Statement

    Financials in CNY. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -94.63M -1.14B -2.17B -2.73B
    Depreciation & Amortization
    		 419.77M 385.1M 319.42M 204.75M
    Stock-Based Compensation
    		 556.52M 574.2M 469.49M 501.57M
    Other Working Capital
    		 447.7M 475.07M -29.63M 551.3M
    Other Non-Cash Items
    		 -44.45M -70.47M -847.15M 37.49M
    Deferred Income Tax
    		 n/a n/a n/a 50.38M
    Change in Working Capital
    		 449.82M 403.39M 309.91M -90.28M
    Operating Cash Flow
    		 1.29B 147.81M -1.92B -2.02B
    Capital Expenditures
    		 -1.71B -1.38B -1.38B -1.85B
    Cash Acquisitions
    		 n/a n/a n/a -630.14M
    Purchase of Investments
    		 n/a -9.41B -10.33B -10.34B
    Sales Maturities Of Investments
    		 n/a 9.24B 10.02B 10.12B
    Other Investing Acitivies
    		 -1.17B 290.87M 252.4M -4.08M
    Investing Cash Flow
    		 -1.17B -998.66M -1.44B -2.7B
    Debt Repayment
    		 -730.44M 418.5M 715.17M 1.21B
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 39.5M -86.36M 45.85M -155.24M
    Financial Cash Flow
    		 -606.63M 2.59B 2.89B 5B
    Net Cash Flow
    		 -472.34M 1.73B -343.24M 83.23M
    Free Cash Flow
    		 -418.39M -1.24B -3.3B -3.87B

    Add to Watchlist